SWOG clinical trial number
SWOG-9520
Controlled Phase II Study of Doxorubicin and Paclitaxel as Frontline Chemotherapy for Women with Metastatic Breast Cancer
Closed
Phase
Accrual
100%
Published
Abbreviated Title
Controlled Phase II Study of Doxorubicin and Paclitaxel as Frontline Chemotherapy for Women with Metastatic Breast Cancer
Activated
12/15/1995
Closed
10/01/1997
Publication Information Expand/Collapse
2004
A Southwest Oncology Group randomized phase II study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer